Aug 12, 2026 04:05PM
Jul 28, 2026 06:21AM
Jul 28, 2026 06:15AM
Jul 13, 2026 04:05PM
Jul 13, 2026 04:05PM
Jul 10, 2026 11:49AM
Jun 29, 2026 01:59AM AB Science reports phase 1 data for AB8939 plus venetoclax in AML
Jun 29, 2026 01:59AM
Jun 17, 2026 12:04PM
Jun 10, 2026 04:05PM
Jun 10, 2026 04:05PM
Jun 9, 2026 12:47PM
Jun 2, 2026 12:05PM
May 25, 2026 12:06PM AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
May 13, 2026 01:36PM
May 11, 2026 04:05PM
Apr 28, 2026 06:16AM
Apr 28, 2026 06:15AM
Apr 27, 2026 12:06PM
Apr 20, 2026 03:37PM
Apr 20, 2026 03:32PM AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients
Apr 16, 2026 01:20PM
Apr 13, 2026 04:05PM
Mar 11, 2026 04:05PM
Feb 24, 2026 12:02PM
Feb 11, 2026 04:05PM
Feb 5, 2026 06:22AM
Feb 5, 2026 06:20AM ALLIANCEBERNSTEIN HOLDING L.P. ANNOUNCES FOURTH QUARTER RESULTS
Jan 29, 2026 12:01PM
Jan 29, 2026 12:00PM
Jan 21, 2026 12:02PM
Jan 12, 2026 04:05PM
Jan 7, 2026 12:03PM
Jan 7, 2026 12:02PM
Dec 22, 2025 11:57AM AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040
Dec 18, 2025 01:17PM
Dec 15, 2025 12:39PM
Dec 11, 2025 12:29PM
Dec 10, 2025 04:07PM
Dec 10, 2025 04:05PM
Nov 11, 2025 04:05PM
Nov 11, 2025 04:05PM AB Announces October 31, 2025 Assets Under Management
Oct 23, 2025 06:21AM
Oct 23, 2025 06:20AM
Oct 16, 2025 02:58PM
Oct 16, 2025 02:57PM
Oct 14, 2025 02:36AM
Oct 14, 2025 02:36AM
Oct 10, 2025 12:10PM AB Science today reports its revenues for the first half of 2025 and provides an update on its activities
Oct 9, 2025 04:05PM

1,221,968 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All